The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration

Familial Hypercholesterolaemia (FH) is severely under-recognized, under-diagnosed and under-treated in Europe, leading to a significantly higher risk of premature cardiovascular diseases in those affected. FH stands for inherited, very high cholesterol and affects 1:300 individuals regardless of their age, race, sex, and lifestyle, making it the most common inherited metabolic disorder and a non-modifiable cardiovascular disease risk factor in the world.

.

Descrição

Review

Palavras-chave

Familial Hypercholesterolaemia FH Screening Children Cardiovascular Disease CVD Prevention Cardiovascular Health CVH Declaration Public Health Health Systems EU Europe EU Best Practice Implementation Doenças Cardio e Cérebro-vasculares

URI

http://hdl.handle.net/10400.18/8466

Citação

GMS Health Innov Technol. 2022 Sep 30;16:Doc04. doi: 10.3205/hta000136. eCollection 2022. Review

Editora

German Medical Science

DOI

10.3205/hta000136

Coleções

DPSPDNT - Artigos em revistas internacionais

Licença CC

cclicense-by

Métricas Alternativas

Ver registo completo